WO2025237176 - RNAI AGENT FOR INHIBITING EXPRESSION OF GPR75 GENE, PREPARATION METHOD THEREFOR AND USE THEREOF
National phase entry is expected:
Publication Number
WO/2025/237176
Publication Date
20.11.2025
International Application No.
PCT/CN2025/093708
International Filing Date
09.05.2025
Title **
[English]
RNAI AGENT FOR INHIBITING EXPRESSION OF GPR75 GENE, PREPARATION METHOD THEREFOR AND USE THEREOF
[French]
AGENT ARNI POUR INHIBER L'EXPRESSION DU GÈNE GPR75, SON PROCÉDÉ DE PRÉPARATION ET SON UTILISATION
[Chinese]
用于抑制GPR75基因表达的RNAi剂及其制备方法和用途
Applicants **
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD
Inventors
WU, Junjun
JIANG, Wenjuan
LI, Jiani
YANG, Lixin
ZHANG, Weiji
HONG, Yinuo
LI, Lili
XIAO, Ying
LU, Yinsuo
Priority Data
202410585648.3
11.05.2024
CN
202410775454.X
14.06.2024
CN
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
CNIPA
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| Translation |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 1678 | |
| EPO | Filing, Examination, Granting | 11887 | |
| Japan | Filing, Examination, Granting | 2017 | |
| South Korea | Filing, Examination, Granting | 1812 | |
| USA | Filing, Examination, Granting | 4740 |
Total:
22,134
Contact Us
Abstract[English]
Provided are an RNAi agent for inhibiting the expression of the GPR75 gene, a preparation method therefor and the use thereof. The RNAi agent can inhibit the expression of the GPR75 gene, so as to treat GPR75 gene-related diseases and disorders, such as obesity.[French]
L'invention concerne un agent ARNi pour inhiber l'expression du gène GPR75, son procédé de préparation et son utilisation. L'agent ARNi peut inhiber l'expression du gène GPR75, de façon à traiter des maladies et des troubles liés au gène GPR75, tels que l'obésité.[Chinese]
提供了用于抑制GPR75基因表达的RNAi剂及其制备方法和用途，所述RNAi剂可以抑制GPR75基因的表达，以治疗GPR75基因相关疾病和病症，例如肥胖症。